Florent Gros

Chief Executive Officer​ and Founder

Florent Gros is CEO and Co-Founder of Priothera. He has held various leadership positions in venture, intellectual property and transaction matters at Nestlé, Pasteur Merieux Connaught and Novartis in Switzerland, Europe and North America. Florent is a Kaufmann Fellow, a certified European Patent Attorney, and he holds two master’s degrees, in Biotechnology Engineering and Private Law. At Novartis Venture Funds, Florent led investments and served in 17 start-up companies, of which 12 were exited. Since 2019, Florent is also Founder and CEO of Handl Therapeutics, a gene therapy company focusing on AAV-based neurodegenerative therapies.